Imago BioSciences, Inc.
IMGODelisted Jan 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623715
Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Imago BioSciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 62 | +4 |
| Shares | 29.9M | 2.15K | 31.1M | +1.26M (+4.2%) |
| Value | $575.8M | $41.0K | $416.8M | −$158.9M (−27.6%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Imago BioSciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Trexquant Investment LP | 32,045 | $429.0K | 0.02% |
| Raymond James & Associates | 26,097 | $349.0K | 0.00% |
| Gsa Capital Partners LLP | 23,835 | $319.0K | 0.05% |
| Regency Capital Management Inc. | 18,050 | $242.0K | 0.26% |
| Susquehanna International Group, LLP | 12,473 | $167.0K | 0.00% |
| Credit Suisse AG | 8,874 | $119.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,141 | $15.0K | 0.00% |
| Nisa Investment Advisors, LLC | 840 | $11.0K | 0.00% |
| CWM, LLC | 15 | $0 | 0.00% |
Sold out (5)
Institutions that held Imago BioSciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Kingdon Capital Management, L.L.C. | 260,118 | $5.01M |
| Laurion Capital Management LP | 40,000 | $771.0K |
| Allspring Global Investments Holdings, LLC | 3,541 | $68.0K |
| STRS Ohio | 2,200 | $42.0K |
| UBS Group AG | 1,288 | $25.0K |
Not filed for Q2 2022 yet (1)
Institutions that held Imago BioSciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,145 | $41.0K |